Choosing Between Wegovy Providers in the UK

The decision you are really making when you pick a provider

Choosing between Wegovy providers is not quite the same as choosing between supermarkets for a weekly shop. You are selecting a clinical relationship that could run for a year or more, through dose changes, side effects and life events that affect treatment. The medicine itself is identical wherever it comes from; the difference is everything around it.

There are broadly three types of provider currently operating in the UK. First, NHS routes: the NICE recommendation for semaglutide (Wegovy) is clear that NHS supply should sit within a specialist weight management service with multidisciplinary support, and waiting lists in many areas are measured in months or longer. Second, private clinics with in-person consultations. Third, regulated online providers, which now handle the majority of private prescriptions for Wegovy. Online provision is entirely legitimate when the pharmacy holds a GPhC registration, you can check any provider at the GPhC register before handing over any personal or payment details.

The real decision, then, is not online versus in-person. It is: which provider has the clinical infrastructure to look after you properly for the duration of treatment, not just long enough to take your first payment?

Red flags and green flags when assessing UK Wegovy providers online

A few things should give you genuine pause. Any provider offering Wegovy without a consultation, at a price that seems implausibly low, or through a social media channel with no verifiable pharmacy registration is not a safe option. The MHRA has warned repeatedly about counterfeit weight-loss pens circulating online, fake pens have contained insulin rather than semaglutide, with serious consequences for some people who received them. The Yellow Card scheme is where you can report a suspected counterfeit or an adverse reaction, and it is worth bookmarking regardless of who you use.

Green flags look like this: a GPhC registration number you can actually verify, a named prescriber rather than an anonymous process, identity and weight checks before treatment starts, and a clear pathway for clinical re-review at each repeat. If a provider's website cannot answer the question "who reviews my prescription?", that is worth noting.

It is also worth asking what happens if your dose needs to change. Titrating up through 0.5mg, 1.0mg, 1.7mg and eventually 2.4mg (or the newer 7.2mg maintenance dose approved by the MHRA in 2026) is a clinical process, not an admin one. Good semaglutide providers treat each step as a fresh clinical decision, not a rubber stamp.

Cost, inclusions and what 'one price' actually means

Pricing between Wegovy providers in the UK can look similar at first glance and diverge sharply once you read the small print. Some headline prices exclude the consultation, the prescription fee, delivery and any aftercare beyond the initial sale. A lower number that requires four add-ons to function as a service is not actually lower.

It is also worth considering timing. Payday orders, Monday morning starts, treatment around a holiday, a provider that only dispatches twice a week or operates no aftercare at weekends will handle these less smoothly than one with daily dispatch and seven-day clinical support.

On the where to buy Wegovy page we go into the cost landscape in more detail. For now, the useful frame is this: the right comparison is not provider A's headline number versus provider B's. It is the total cost of a safe, well-managed course of treatment. For a prescription medicine, the cheapest listing often answers the wrong question entirely.

At nume, our model is one transparent price that covers the free consultation, the prescription, the medicine, free next-working-day delivery via DPD and priority aftercare seven days a week. No auto-renewals. A named, GPhC-registered Independent Prescriber reviews every consultation personally. You can read more about how we work on our about us page or review the clinical team's credentials via our clinical team profile.

Eligibility: what providers should be checking before they prescribe

The licensed criteria for Wegovy sit at a BMI of 30 or above, or 27 to 29.9 alongside at least one weight-related condition such as high blood pressure, raised cholesterol or type 2 diabetes. Lower thresholds apply for people from some ethnic backgrounds under UK guidance. That is the framework; a responsible prescriber also looks at your medical history, current medicines and whether there are any contraindications before issuing a prescription.

A provider that skips those checks (or relies on a short self-completed questionnaire with no verification) is not meeting the standard a proper clinical assessment requires. Pregnancy, breastfeeding and trying to conceive are situations in which Wegovy is not recommended; under-18s are outside the licensed indication. These are not boxes to tick; they are clinical judgements a real prescriber needs to make. If you are curious about how to get Wegovy without being overweight, that page explains the eligibility nuances in full, including the lower BMI thresholds and the conditions that may qualify you.

If you are thinking about switching from a provider you are already using, the switching Wegovy provider page covers what to expect and what clinical evidence is typically required. For a broader look at how semaglutide works and what the evidence shows, and to find Wegovy providers near you, the Wegovy overview is a good starting point.